Form 8-K - Current report:
SEC Accession No. 0000950135-05-003454
Filing Date
2005-06-24
Accepted
2005-06-24 15:00:26
Documents
2
Period of Report
2005-06-20
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 ALNYLAM PHARMACEUTICALS, INC. b55656ape8vk.htm 8-K 12828
2 EX-10.1 AMENDMENT NO. 02 TO LOAN AND SECURITY AGREEMENT b55656apexv10w1.htm EX-10.1 9399
  Complete submission text file 0000950135-05-003454.txt   23775
Mailing Address 300 THIRD STREET CAMBRIDGE MA 02142
Business Address 300 THIRD STREET CAMBRIDGE MA 02142 (617) 551-8200
ALNYLAM PHARMACEUTICALS, INC. (Filer) CIK: 0001178670 (see all company filings)

EIN.: 770602661
Type: 8-K | Act: 34 | File No.: 000-50743 | Film No.: 05914929
SIC: 2834 Pharmaceutical Preparations